Milo Frattini
Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial
Siano M, Espeli V, Mach N, Bossi P, Licitra L, Ghielmini M, Frattini M, Canevari S, De Cecco L. Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial. Oral Oncol 2018; 82:144-151.
May 28, 2018Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial
May 28, 2018Oral Oncol 2018; 82:144-151
Siano Marco, Espeli Vittoria, Mach Nicolas, Bossi Paolo, Licitra Lisa, Ghielmini Michele, Frattini Milo, Canevari Silvana, De Cecco Loris
Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer
Siano M, Frattini M, Ghielmini M, Corradino I, Freguia S, Früh M, Mach N, Martin V, Molinari F, Espeli V. Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer. Oncologist 2017
Jun 7, 2017Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer
Jun 7, 2017Oncologist 2017
Siano Marco, Frattini Milo, Ghielmini Michele, Corradino Irene, Freguia Stefania, Früh Martin, Mach Nicolas, Martin Vittoria, Molinari Francesca, Espeli Vittoria